Tazegul G, Ogut T S, Bozoglan H, Dogan O, Yilmaz N, Ulas T, Salim O, Sari R, Altunbas H A, Balci M K
.
Endocr Regul. 2017 Jul 1;51(3):153-156. doi: 10.1515/enr-2017-0016.
Thrombotic thrombocytopenic purpura (TTP) is a rare disease characterized by microangiopathic hemolytic anemia, thrombocytopenic purpura, neurologic abnormalities, fever, and renal insufficiency. The association or co-existence of thyrotoxicosis or antithyroid drugs with TTP has not been previously reported. Subject and Results. Herein, we present a 54-year-old female patient newly diagnosed with toxic multinodular goiter accompanying with TTP, possibly triggered by either thyrotoxicosis or antithyroid drugs.
The present report is the first in the literature to demonstrate the co-existence of these two diseases and the use of plasma exchange as a modality to treat both conditions.
血栓性血小板减少性紫癜(TTP)是一种罕见疾病,其特征为微血管病性溶血性贫血、血小板减少性紫癜、神经异常、发热和肾功能不全。甲状腺毒症或抗甲状腺药物与TTP的关联或共存此前尚未见报道。病例与结果。在此,我们报告一名54岁女性患者,新诊断为毒性多结节性甲状腺肿合并TTP,可能由甲状腺毒症或抗甲状腺药物引发。
本报告是文献中首例证明这两种疾病共存以及使用血浆置换治疗这两种病症的报道。